Andrew Berens
Stock Analyst at Leerink Partners
(4.86)
# 374
Out of 5,036 analysts
557
Total ratings
47.3%
Success rate
23.4%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $40 | $16.61 | +140.82% | 1 | Sep 21, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Rated: Buy | $27 → $25 | $3.44 | +626.74% | 5 | Sep 18, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | $7 | $1.02 | +586.27% | 26 | Aug 7, 2026 | |
| EXEL Exelixis | Downgraded: Hold | $48 → $52 | $58.44 | -11.02% | 13 | Aug 6, 2026 | |
| INCY Incyte | Reiterated: Buy | $103 → $155 | $113.44 | +36.64% | 62 | Aug 3, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Buy | n/a | $31.79 | - | 52 | Jul 7, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $40 | $28.82 | +38.79% | 1 | Jul 6, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | n/a | $6.46 | - | 28 | Jun 2, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $46 → $51 | $20.24 | +151.98% | 2 | May 15, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 → $33 | $19.10 | +72.82% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 → $43 | $14.66 | +193.32% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $55 | $21.83 | +151.95% | 26 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $14.05 | +63.70% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.25 | +146.15% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $40 | $26.53 | +50.77% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $97 | $65.78 | +47.46% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $30.14 | +65.89% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $3.86 | +288.60% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $36.26 | -8.99% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.63 | n/a | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $2.35 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $17.95 | n/a | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $2.64 | n/a | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $7.45 | n/a | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $364.02 | n/a | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.55 | n/a | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18.00 | $8.16 | n/a | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $0.38 | $0.365 | n/a | 25 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $168.33 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $70.67 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 → $25 | $2.82 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $15 | $10.17 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.81 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $9.83 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $88.45 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $8 | $7.23 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.8734 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $8.22 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $37.80 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.40 | n/a | 2 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $146.85 | n/a | 3 | Dec 1, 2014 |
BlossomHill Therapeutics
Sep 21, 2026
Reiterated: Buy
Price Target: $40
Current: $16.61
Upside: +140.82%
BridgeBio Oncology Therapeutics
Sep 18, 2026
Rated: Buy
Price Target: $27 → $25
Current: $3.44
Upside: +626.74%
Compass Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $7
Current: $1.02
Upside: +586.27%
Exelixis
Aug 6, 2026
Downgraded: Hold
Price Target: $48 → $52
Current: $58.44
Upside: -11.02%
Incyte
Aug 3, 2026
Reiterated: Buy
Price Target: $103 → $155
Current: $113.44
Upside: +36.64%
Agios Pharmaceuticals
Jul 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.79
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $28.82
Upside: +38.79%
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.46
Upside: -
Damora Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $46 → $51
Current: $20.24
Upside: +151.98%
Immunome
May 15, 2026
Reiterated: Buy
Price Target: $40 → $33
Current: $19.10
Upside: +72.82%
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $14.66
Upside: +193.32%
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $21.83
Upside: +151.95%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $14.05
Upside: +63.70%
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $3.25
Upside: +146.15%
Nov 19, 2025
Reiterated: Buy
Price Target: $24 → $40
Current: $26.53
Upside: +50.77%
Nov 17, 2025
Reiterated: Buy
Price Target: $70 → $97
Current: $65.78
Upside: +47.46%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $30.14
Upside: +65.89%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $3.86
Upside: +288.60%
Oct 21, 2025
Reiterated: Hold
Price Target: $30 → $33
Current: $36.26
Upside: -8.99%
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.63
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $33
Current: $2.35
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $17.95
Upside: n/a
Aug 11, 2025
Reiterated: Hold
Price Target: $3
Current: $2.64
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $9
Current: $7.45
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $364.02
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $2.55
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $18.00
Current: $8.16
Upside: n/a
Jun 11, 2025
Reiterated: Hold
Price Target: $1 → $0.38
Current: $0.365
Upside: n/a
Feb 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $168.33
Upside: n/a
Dec 10, 2024
Reiterated: Buy
Price Target: n/a
Current: $70.67
Upside: n/a
Feb 7, 2023
Reiterated: Buy
Price Target: $67 → $25
Current: $2.82
Upside: n/a
Feb 7, 2023
Reiterated: Hold
Price Target: $20 → $15
Current: $10.17
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: n/a
Current: $44.81
Upside: n/a
May 7, 2021
Reiterated: Hold
Price Target: $10
Current: $9.83
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Reiterated: Hold
Price Target: $23
Current: $88.45
Upside: n/a
Jul 14, 2017
Reiterated: Hold
Price Target: $16 → $8
Current: $7.23
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $0.8734
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $8.22
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $37.80
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $12.40
Upside: n/a
Dec 1, 2014
Reiterated: Hold
Price Target: n/a
Current: $146.85
Upside: n/a